garenoxacin has been researched along with sitafloxacin in 7 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (sitafloxacin) | Trials (sitafloxacin) | Recent Studies (post-2010) (sitafloxacin) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 16 | 0 | 3 |
| 195 | 19 | 46 | 185 | 22 | 85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W | 1 |
| Hibi, T; Muraoka, H; Nishizawa, T; Suzuki, H | 1 |
| Fujioka, T; Hasegawa, M; Ikeda, F; Kobayashi, I; Kodama, M; Murakami, K; Muraoka, H; Okimoto, T; Saika, T; Takigawa, M; Tanahashi, J | 1 |
| Finegold, S; Goldstein, E; Gorbach, SL; Harrell, L; Hecht, DW; Jacobus, NV; Jenkins, S; McDermott, LA; Pierson, C; Rihs, J; Ruthazer, R; Snydman, DR; Venezia, R | 1 |
| Hoshino, K; Okumura, R; Otani, T; Yamamoto, T | 1 |
| Kanayama Katsuse, A; Kaneko, A; Kanesaka, I; Kobayashi, I; Nakanishi, Y; Okumura, R; Takahashi, H | 1 |
| Fukuda, Y; Fukushima, K; Hashiguchi, K; Higashiyama, Y; Imamura, Y; Inoue, Y; Izumikawa, K; Kobayashi, T; Koga, H; Kohno, S; Kondo, A; Mikushi, S; Miyazaki, T; Morinaga, Y; Mukae, H; Nagayoshi, Y; Nakamura, S; Saijo, T; Sasaki, E; Takazono, T; Yamamoto, K; Yanagihara, K; Yoshida, M | 1 |
1 trial(s) available for garenoxacin and sitafloxacin
| Article | Year |
|---|---|
The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Japan; Male; Pneumonia; Quinolones | 2019 |
6 other study(ies) available for garenoxacin and sitafloxacin
| Article | Year |
|---|---|
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors | 2007 |
Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation.
Topics: Anti-Infective Agents; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Helicobacter pylori; Mutation | 2009 |
Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations.
Topics: Anti-Bacterial Agents; DNA Gyrase; Fluoroquinolones; Helicobacter pylori; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin | 2009 |
In vitro activities of newer quinolones against bacteroides group organisms.
Topics: Anti-Infective Agents; Aza Compounds; Bacteroides; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |
Quinolones with enhanced bactericidal activity induce autolysis in Streptococcus pneumoniae.
Topics: Aminopyridines; Anti-Bacterial Agents; Bacteriolysis; Fluoroquinolones; Microbial Sensitivity Tests; N-Acetylmuramoyl-L-alanine Amidase; Streptococcus pneumoniae | 2009 |
Gene expression analysis in the potent bactericidal activity of sitafloxacin against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacteriocins; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2019 |